Debt-to-equity of Centessa Pharmaceuticals plc from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Centessa Pharmaceuticals plc quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 30 Sep 2025.
Centessa Pharmaceuticals plc Debt-to-equity for the quarter ending 30 Sep 2025 was 43%, a 15% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Centessa Pharmaceuticals plc Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	43%	+5.5%	+15%	30 Sep 2025
Q2 2025	35%	-12%	-25%	30 Jun 2025
Q1 2025	34%	-13%	-28%	31 Mar 2025
Q4 2024	36%	-7.6%	-17%	31 Dec 2024
Q3 2024	37%	-1.7%	-4.5%	30 Sep 2024
Q2 2024	47%	+12%	+36%	30 Jun 2024
Q1 2024	48%	+18%	+59%	31 Mar 2024
Q4 2023	44%	+18%	+70%	31 Dec 2023
Q3 2023	39%	+14%	+53%	30 Sep 2023
Q2 2023	35%	+14%	+66%	30 Jun 2023
Q1 2023	30%	+13%	+75%	31 Mar 2023
Q4 2022	26%			31 Dec 2022
Q3 2022	25%			30 Sep 2022
Q2 2022	21%			30 Jun 2022
Q1 2022	17%			31 Mar 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.